Nasso Giuseppe, Anselmi Amedeo, De Filippo Carlo Maria, Modugno Pietro, Canosa Carlo, Spatuzza Paola, Testa Nicola, Guerrieri Massimiliano Walter, Calvo Eugenio, Alessandrini Francesco
Division of Cardiac Surgery, Centro di Ricerca e Formazione ad Alta Tecnologia nelle Scienze Biomediche, Università Cattolica del Sacro Cuore, Loc. Tappino, Campobasso, Italy.
J Cardiovasc Med (Hagerstown). 2007 Jul;8(7):511-6. doi: 10.2459/01.JCM.0000278447.12236.9f.
Diabetes mellitus is an established risk factor for leg wound healing complications after great saphenous vein harvest. Leg healing complications occur in 1-25% of coronary artery bypass graft patients, and are often underestimated.
The records of 230 patients enrolled in a prospective trial to evaluate a minimally invasive approach compared with conventional longitudinal harvest were reviewed. Of 100 patients with diabetes, 49 had undergone minimally invasive harvest (group A). Forty-nine patients from the pool without diabetes who underwent minimally invasive harvest were selected using propensity scoring analysis (group B), and 46 diabetic patients operated using a conventional technique (group C) were matched to group A patients. Ninety-five patients with and 49 without diabetes finally entered the study. The quality of leg wound healing was quantified by ASEPSIS score by two independent surgeons in a blinded manner. The occurrence of complications was compared between groups.
Fewer leg wound healing complications occurred in diabetic patients in the minimally invasive compared with the conventional group (P < 0.0001). Rates of complications were comparable among diabetic and non-diabetic patients operated using the minimally invasive technique. The intraoperative flow of vein grafts obtained by the minimally invasive technique was comparable to that of veins harvested using the conventional technique.
These data suggest that postoperative leg wound morbidity can be significantly attenuated by the adoption of a less invasive approach, even in high-risk patients with diabetes. The advantages are not offset by the co-existence of other cardiovascular risk factors or by a long history of diabetes.
糖尿病是大隐静脉采集后腿部伤口愈合并发症的既定危险因素。腿部愈合并发症发生在1%-25%的冠状动脉旁路移植术患者中,且常被低估。
回顾了230例参与前瞻性试验的患者记录,该试验旨在评估微创方法与传统纵向采集方法的对比。在100例糖尿病患者中,49例接受了微创采集(A组)。使用倾向评分分析从无糖尿病患者中选取49例接受微创采集的患者(B组),并将46例采用传统技术手术的糖尿病患者(C组)与A组患者进行匹配。最终95例有糖尿病患者和49例无糖尿病患者进入研究。由两名独立外科医生以盲法通过ASEPSIS评分对腿部伤口愈合质量进行量化。比较各组并发症的发生情况。
与传统组相比,微创组糖尿病患者发生的腿部伤口愈合并发症更少(P<0.0001)。采用微创技术手术的糖尿病患者和非糖尿病患者的并发症发生率相当。微创技术获取的静脉移植物的术中血流量与传统技术获取的静脉相当。
这些数据表明,即使在糖尿病高危患者中,采用侵入性较小的方法也可显著降低术后腿部伤口发病率。这些优势不会因其他心血管危险因素的共存或糖尿病的长期病史而抵消。